• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估肥胖、饮食血糖指数和代谢特征对经典型苯丙酮尿症患儿心血管风险的影响。

Evaluation of the effect of obesity, dietary glycemic index and metabolic profiles on the cardiovascular risk in children with classical phenylketonuria.

机构信息

Department of Pediatric Metabolism, Konya City Hospital, University of Health Sciences, Konya, Turkey.

Department of Pediatric Cardiology, Erciyes University Medical Faculty, Kayseri, Turkey.

出版信息

Mol Genet Metab. 2023 Nov;140(3):107677. doi: 10.1016/j.ymgme.2023.107677. Epub 2023 Aug 2.

DOI:10.1016/j.ymgme.2023.107677
PMID:37544048
Abstract

OBJECTIVES

To compare the glycemic index(GI),obesity,echocardiographic,and arterial stiffness measurements with the healthy control group to evaluate the cardiovascular risk of pediatric classical phenylketonuria(PKU).

METHODS

The study was a prospective observational,involving 104 pediatric volunteers between 2019 and 2020.Two groups were formed:the PKU patient group and the healthy control group.These two groups were further divided into three subgroups:obese,overweight,and normal weight.The patients' anthropometric measurements,body fat analysis,biochemical analysis, GI and glycemic load(GL),arterial stiffness measurements,and echocardiographic findings were recorded.

RESULTS

The PKU patient group's glucose,total cholesterol,LDL,and HDL values were significantly lower than the healthy control group(p = 0.010 for glucose and p = 0.001 for total cholesterol,LDL and HDL).Triglyceride levels were higher in the PKU patient group than in the healthy controls(109.6 vs. 76.7 mg/dl,p = 0.001). GI and GL were significantly lower in the PKU patient group than in the healthy control group(GI 453 vs. 392.9,p = 0.017 and GL 101.1 vs. 85.5,p = 0.036).Left ventricular mass(LVM)-z-score and LVM index were significantly higher in the PKU group than in the healthy control group(LVM z-score 0.9 vs. 0.5,p = 0.014 and LVM index 38.9 vs. 32.7 g/m,p = 0.001). A moderately statistically significant positive correlation was found between the mean phenylalanine(phe) value and pulse wave velocity(PWV) among the PKU patient groups(R: 0.477,p < 0.001).A moderately statistically significant positive correlation was also found between waist circumference and PWV in the PKU patient group(R:0.541, p < 0.001).

CONCLUSIONS

Our study found that close follow-up of phe levels and PWV is more critical than obesity, GI, and GL in the cardiovascular evaluation of classical PKU patients.A large number of multicenter pediatric studies are needed in this area.

摘要

目的

比较血糖指数(GI)、肥胖、超声心动图和动脉僵硬测量值与健康对照组,以评估儿科经典苯丙酮尿症(PKU)的心血管风险。

方法

本研究为前瞻性观察性研究,纳入 2019 年至 2020 年期间的 104 名儿科志愿者。将志愿者分为两组:PKU 患者组和健康对照组。将这两组进一步分为三组:肥胖组、超重组和正常体重组。记录患者的人体测量、体脂分析、生化分析、GI 和血糖负荷(GL)、动脉僵硬测量和超声心动图检查结果。

结果

PKU 患者组的血糖、总胆固醇、LDL 和 HDL 值明显低于健康对照组(血糖:p=0.010;总胆固醇、LDL 和 HDL:p=0.001)。PKU 患者组的甘油三酯水平高于健康对照组(109.6 比 76.7mg/dl,p=0.001)。PKU 患者组的 GI 和 GL 明显低于健康对照组(GI:453 比 392.9,p=0.017;GL:101.1 比 85.5,p=0.036)。PKU 组的左心室质量(LVM)-z 评分和 LVM 指数明显高于健康对照组(LVM-z 评分:0.9 比 0.5,p=0.014;LVM 指数:38.9 比 32.7g/m,p=0.001)。在 PKU 患者组中,平均苯丙氨酸(phe)值与脉搏波速度(PWV)之间存在中度统计学显著正相关(R:0.477,p<0.001)。在 PKU 患者组中,腰围与 PWV 之间也存在中度统计学显著正相关(R:0.541,p<0.001)。

结论

本研究发现,与肥胖、GI 和 GL 相比,密切监测 phe 水平和 PWV 对经典 PKU 患者的心血管评估更为重要。在这一领域需要开展大量的多中心儿科研究。

相似文献

1
Evaluation of the effect of obesity, dietary glycemic index and metabolic profiles on the cardiovascular risk in children with classical phenylketonuria.评估肥胖、饮食血糖指数和代谢特征对经典型苯丙酮尿症患儿心血管风险的影响。
Mol Genet Metab. 2023 Nov;140(3):107677. doi: 10.1016/j.ymgme.2023.107677. Epub 2023 Aug 2.
2
Dietary glycemic index, glycemic load and metabolic profile in children with phenylketonuria.苯丙酮尿症患儿的膳食血糖生成指数、血糖负荷与代谢谱
Nutr Metab Cardiovasc Dis. 2017 Feb;27(2):176-182. doi: 10.1016/j.numecd.2016.11.002. Epub 2016 Nov 21.
3
Arterial stiffness assessment in patients with phenylketonuria.苯丙酮尿症患者的动脉僵硬度评估
Medicine (Baltimore). 2017 Dec;96(51):e9322. doi: 10.1097/MD.0000000000009322.
4
The value of waist circumference as a preditor of cardiovascular risk in adult patients with classic phenylketonuria.经典型苯丙酮尿症成年患者腰围预测心血管风险的价值。
Med Clin (Barc). 2023 Dec 7;161(11):470-475. doi: 10.1016/j.medcli.2023.06.027. Epub 2023 Aug 3.
5
Phenylketonuric diet negatively impacts on butyrate production.苯丙酮尿症饮食对丁酸产生有负面影响。
Nutr Metab Cardiovasc Dis. 2018 Apr;28(4):385-392. doi: 10.1016/j.numecd.2018.01.004. Epub 2018 Jan 31.
6
Effects of dietary glycemic index and load on children's cardiovascular risk factors.膳食血糖指数和负荷对儿童心血管危险因素的影响。
Ann Epidemiol. 2019 Dec;40:1-7.e3. doi: 10.1016/j.annepidem.2019.10.005. Epub 2019 Oct 25.
7
Carbohydrate status in patients with phenylketonuria.苯丙酮尿症患者的碳水化合物状况。
Orphanet J Rare Dis. 2018 Jun 27;13(1):103. doi: 10.1186/s13023-018-0847-x.
8
Plasma cholesterol in adults with phenylketonuria.苯丙酮尿症成年患者的血浆胆固醇
Pathology. 2015 Feb;47(2):134-7. doi: 10.1097/PAT.0000000000000210.
9
Lipid profile status and other related factors in patients with Hyperphenylalaninaemia.高苯丙氨酸血症患者的血脂状况及其他相关因素
Orphanet J Rare Dis. 2016 Sep 9;11(1):123. doi: 10.1186/s13023-016-0508-x.
10
The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD).低果糖和低血糖指数/负荷(FRAGILE)饮食干预对非酒精性脂肪性肝病(NAFLD)儿童和青少年肝功能指标、心脏代谢危险因素及身体成分的影响。
JPEN J Parenter Enteral Nutr. 2015 Jan;39(1):73-84. doi: 10.1177/0148607113501201. Epub 2013 Aug 23.

引用本文的文献

1
Metabolomics and Lipidomics Explore Phenotype-Specific Molecular Signatures for Phenylketonuria.代谢组学和脂质组学探索苯丙酮尿症的表型特异性分子特征。
Int J Mol Sci. 2025 Jul 25;26(15):7171. doi: 10.3390/ijms26157171.
2
The association of plasma level of phenylalanine with inflammatory markers, insulin resistance, and atherosclerotic indexes in patients with phenylketonuria.苯丙酮尿症患者血浆苯丙氨酸水平与炎症标志物、胰岛素抵抗及动脉粥样硬化指标的相关性
J Diabetes Metab Disord. 2025 May 14;24(1):119. doi: 10.1007/s40200-025-01631-7. eCollection 2025 Jun.
3
Antioxidant and Anti-Inflammatory Activity of a New Formulation of Slow-Release Amino Acids in Human Intestinal Caco-2 Cells.
缓释氨基酸新制剂在人肠道Caco-2细胞中的抗氧化和抗炎活性
Antioxidants (Basel). 2025 Feb 26;14(3):271. doi: 10.3390/antiox14030271.
4
The relationship between adult phenylketonuria and the cardiovascular system - insights into mechanisms and risks.成人苯丙酮尿症与心血管系统的关系——对机制和风险的见解
Orphanet J Rare Dis. 2025 Apr 2;20(1):156. doi: 10.1186/s13023-025-03686-4.
5
Current Insights into Nutritional Management of Phenylketonuria: An Update for Children and Adolescents.苯丙酮尿症营养管理的最新见解:儿童和青少年最新情况
Children (Basel). 2025 Feb 7;12(2):199. doi: 10.3390/children12020199.
6
Growth Parameters and Prevalence of Obesity in PKU Patients and Peers: Is This the Right Comparison?苯丙酮尿症患者及其同龄人肥胖的生长参数和患病率:这样比较合适吗?
Pediatr Rep. 2024 Oct 16;16(4):892-901. doi: 10.3390/pediatric16040076.